STOCKWATCH
·
Pharmaceuticals
Buyback12 Mar 2026, 02:02 pm

Jagsonpal Pharmaceuticals Ltd. Announces Buyback of Up to 16 Lakh Equity Shares at Rs. 250 Each

AI Summary

Jagsonpal Pharmaceuticals Ltd. has approved a proposal for buyback of equity shares in compliance with Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018. The company plans to buy back up to 16,00,000 (16 lakhs) equity shares, representing 2.39% of the paid-up equity capital, at a price of Rs. 250.00 per equity share. The maximum buyback offer size is Rs. 40,00,00,000 (Rupees Forty Crores only). The buyback will be undertaken through the ‘tender offer’ route on a proportionate basis. The promoters/promoter group will not be participating in the proposed buyback.

Key Highlights

  • Buyback of up to 16,00,000 equity shares
  • Buyback price set at Rs. 250.00 per equity share
  • Maximum buyback offer size of Rs. 40,00,00,000
  • Buyback to be undertaken through the ‘tender offer’ route
  • Promoters/promoter group will not participate in the buyback
JAGSNPHARM
Pharmaceuticals
JAGSONPAL PHARMACEUTICALS LTD.

Price Impact